MTNB
Price
$1.90
Change
-$0.00 (-0.00%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
10.55M
Intraday Buy/Sell Signals
VKTX
Price
$34.67
Change
+$1.62 (+4.90%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
3.72B
6 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

MTNB vs VKTX

Header iconMTNB vs VKTX Comparison
Open Charts MTNB vs VKTXBanner chart's image
Matinas Biopharma Holdings
Price$1.90
Change-$0.00 (-0.00%)
Volume$4.1K
Capitalization10.55M
Viking Therapeutics
Price$34.67
Change+$1.62 (+4.90%)
Volume$8.91K
Capitalization3.72B
MTNB vs VKTX Comparison Chart in %
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTNB vs. VKTX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTNB is a Hold and VKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (MTNB: $1.90 vs. VKTX: $33.05)
Brand notoriety: MTNB and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTNB: 5% vs. VKTX: 42%
Market capitalization -- MTNB: $10.55M vs. VKTX: $3.72B
MTNB [@Biotechnology] is valued at $10.55M. VKTX’s [@Biotechnology] market capitalization is $3.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTNB’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • MTNB’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both MTNB and VKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTNB’s TA Score shows that 5 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • MTNB’s TA Score: 5 bullish, 1 bearish.
  • VKTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MTNB is a better buy in the short-term than VKTX.

Price Growth

MTNB (@Biotechnology) experienced а +0.53% price change this week, while VKTX (@Biotechnology) price change was +4.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.72B) has a higher market cap than MTNB($10.6M). MTNB YTD gains are higher at: 272.549 vs. VKTX (-17.868). MTNB has higher annual earnings (EBITDA): -11.39M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. MTNB (6.53M). VKTX has less debt than MTNB: VKTX (878K) vs MTNB (2.53M). MTNB (0) and VKTX (0) have equivalent revenues.
MTNBVKTXMTNB / VKTX
Capitalization10.6M3.72B0%
EBITDA-11.39M-212.42M5%
Gain YTD272.549-17.868-1,525%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.53M808M1%
Total Debt2.53M878K288%
FUNDAMENTALS RATINGS
MTNB vs VKTX: Fundamental Ratings
MTNB
VKTX
OUTLOOK RATING
1..100
5217
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
35
Fair valued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
3743
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
857

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (24) in the Biotechnology industry is in the same range as VKTX (35). This means that MTNB’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as MTNB (100). This means that VKTX’s stock grew similarly to MTNB’s over the last 12 months.

VKTX's SMR Rating (95) in the Biotechnology industry is in the same range as MTNB (99). This means that VKTX’s stock grew similarly to MTNB’s over the last 12 months.

MTNB's Price Growth Rating (37) in the Biotechnology industry is in the same range as VKTX (43). This means that MTNB’s stock grew similarly to VKTX’s over the last 12 months.

MTNB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VKTX (100). This means that MTNB’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTNBVKTX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 30 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYNE0.390.02
+5.86%
VYNE Therapeutics
RBBN3.820.12
+3.11%
Ribbon Communications
TIC13.090.34
+2.67%
Acuren Corp
GDDY132.27-0.14
-0.11%
GoDaddy
ATOS1.03-0.02
-2.03%
Atossa Therapeutics

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with ABCZF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
+3.54%
ABCZF - MTNB
37%
Loosely correlated
N/A
SPRC - MTNB
35%
Loosely correlated
-0.58%
EQ - MTNB
35%
Loosely correlated
-2.34%
AXON - MTNB
34%
Loosely correlated
-0.75%
VKTX - MTNB
32%
Poorly correlated
-2.54%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-2.54%
NEVPF - VKTX
45%
Loosely correlated
N/A
SYRE - VKTX
42%
Loosely correlated
+11.02%
GPCR - VKTX
41%
Loosely correlated
+0.03%
TERN - VKTX
39%
Loosely correlated
-1.40%
BCRX - VKTX
38%
Loosely correlated
-8.81%
More